487 studies found for:    Open Studies | "Stomach Diseases"
Show Display Options
Rank Status Study
1 Recruiting Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing
Conditions: Colorectal Cancer;   Stomach Disease
Interventions: Other: FIT(Eiken OC-Sensor) Two-day sampling;   Other: FIT(Eiken OC-Sensor) One-year interval;   Other: FIT(Eiken OC-Sensor) One-day sampling;   Other: FIT(Eiken OC-Sensor) Two-year interval;   Other: HpSA (Firstep Helicobacter pylori Antigen Rapid Test)
2 Unknown  Diagnosis of Gastric Lesions With Na-nose
Condition: Stomach Diseases
Intervention:
3 Recruiting Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks
Conditions: Migraine Headache;   Gastric Diseases
Interventions: Drug: propranolol;   Drug: Quince's oxymel;   Drug: placebo
4 Unknown  Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm
Conditions: Disorder of Stomach Function and Feeding Problems in Newborn;   Feeding and Eating Disorders of Childhood
Interventions: Drug: Triple viable Bifidobacterium 0.5 bid po;   Dietary Supplement: early Micro-feeding
5 Unknown  Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
Conditions: Portal Hypertension Gastropathy;   Esophageal Varices;   Spontaneous Bacterial Peritonitis;   Hepatic Encephalopathy;   Ascites
Interventions: Drug: propranolol;   Drug: carvedilol;   Drug: placebo
6 Unknown  Cytokine Gene Polymorphisms in Gastric Diseases
Conditions: Gastric Ulcer;   Duodenal Ulcer;   Gastric Cancer
Intervention: Procedure: IL-1, TNF-alpha, Il-10
7 Recruiting Domperidone for Refractory Gastrointestinal Disorders
Condition: Gastroparesis
Intervention: Drug: Domperidone
8 Recruiting Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis
Condition: Diabetic Gastroparesis
Interventions: Drug: Metoclopramide Nasal Spray;   Drug: Placebo Nasal Spray
9 Recruiting Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis
Condition: Diabetic Gastroparesis
Interventions: Drug: Metoclopramide Nasal Spray;   Drug: Placebo Nasal Spray
10 Not yet recruiting A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet
Condition: Gastric Ulcer
Interventions: Drug: BRI-1501;   Drug: Lafutidine;   Drug: Irsogladine maleate
11 Recruiting Domperidone for Chronic Nausea and Vomiting
Condition: Gastroparesis
Intervention: Drug: Domperidone
12 Recruiting Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS Study
Condition: Gastric Cancer
Intervention: Other: gastric cancer pts undergoing surgery
13 Recruiting Domestic Surgical Robot Clinical Study
Condition: Gastric Ulcer With Perforation But Without Obstruction,
Intervention: Procedure: robotic surgery
14 Recruiting Robotic, Laparoscopic and Open Gastrectomy Compared on Short and Long Term Outcomes
Condition: Gastric Cancer
Interventions: Procedure: Robotic Gastrectomy;   Procedure: Laparoscopic Gastrectomy
15 Recruiting A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Procedure: Laparoscopic procedures;   Procedure: Open Surgery
16 Recruiting Study of ONO-4538 in Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: ONO-4538;   Drug: Oxaliplatin;   Drug: Tegafur- Gimeracil-Oteracil potassium;   Drug: Capecitabine
17 Recruiting Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (EIPL)
Condition: Gastric Cancer
Intervention: Other: Extensive Intraoperative Peritoneal Lavage
18 Not yet recruiting Monosodium Glutamate on Gastric Emptying
Condition: Delayed Gastric Emptying
Intervention: Dietary Supplement: Monosodium glutamate
19 Recruiting Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.
Condition: Gastric Cancer
Interventions: Drug: S-1 for 6 months;   Drug: S-1 for 1 year
20 Recruiting PEPTIDE RECEPTOR RADIONUCLIDE THERAPY WITH 177Lu-DOTATATE ASSOCIATED WITH METRONOMIC CAPECITABINE IN PATIENTS AFFECTED BY AGGRESSIVE GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE TUMORS
Conditions: Neuroendocrine Tumors;   Gastro Entero Pancreatic Neuroendocrine Tumors
Interventions: Drug: 28 GBq 177Lu-DOTATATE;   Drug: 22 GBq 177Lu-DOTATATE

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years